1.
Nanoscale
; 13(13): 6410-6416, 2021 Apr 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33885522
RESUMO
The control of COVID-19 across the world requires the formation of a range of interventions including vaccines to elicit an immune response and immunomodulatory or antiviral therapeutics. Here, we demonstrate the nanoparticle formulation of a highly insoluble drug compound, niclosamide, with known anti SARS-CoV-2 activity as a cheap and scalable long-acting injectable antiviral candidate.